Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue
This article was originally published in The Pink Sheet Daily
Executive Summary
Data from the pilot program a “driving factor” in the agency’s decision against changing its recommendations for the blood thinner following reports of increased serious bleeding events.